MétaCan
Menu
Back to cohort
Record W3006937281 · doi:10.1200/jgo.19.00380

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts

2020· article· en· W3006937281 on OpenAlexaff
Dominick Bossé, Wanling Xie, Xun Lin, Ronit Simantov, Aly‐Khan A. Lalani, Jeffrey Graham, J. Connor Wells, Frede Donskov, Brian I. Rini, Benoit Beuselinck, Ajjai Alva, Aaron R. Hansen, Lori Wood, Denis Soulières, Christian Kollmannsberger, François Patenaude, Daniel Y.C. Heng, Toni K. Choueiri, Rana R. McKay

Bibliographic record

VenueJCO Global Oncology · 2020
Typearticle
Languageen
FieldMedicine
TopicRenal cell carcinoma treatment
Canadian institutionsQueen Elizabeth II Health Sciences CentreCentre Hospitalier de l’Université de MontréalUniversity of CalgaryCancerCare ManitobaMcMaster UniversityMcGill University Health CentreJuravinski Cancer CentreBC Cancer AgencyPrincess Margaret Cancer CentreOttawa HospitalUniversity of Ottawa
FundersGenentechEisaiIpsenMirati TherapeuticsU.S. Department of DefenseExelixisGlaxoSmithKlineDana-Farber/Harvard Cancer CenterBristol-Myers SquibbEli Lilly and CompanyAstraZenecaCongressionally Directed Medical Research ProgramsAstellas PharmaGateway for Cancer ResearchPfizerKaryopharm Therapeutics
KeywordsRenal cell carcinomaTyrosine kinaseMedicineCancer researchOncologyInternal medicineCarcinoma

Abstract

fetched live from OpenAlex

PURPOSE To investigate whether black race is an independent predictor of overall survival (OS) in metastatic renal cell carcinoma (mRCC). METHODS We performed a retrospective 2-cohort (International Metastatic Renal Cell Carcinoma Database Consortium [IMDC] and trial-database) study of patients with mRCC treated with first-line tyrosine kinase inhibitors (TKIs). Unmatched (UM) and matched (M) analyses accounting for imbalances in region, year of treatment, age, and sex between races were performed. Cox models adjusting for histology, number of metastatic sites, nephrectomy, and IMDC risk compared time to treatment failure (TTF; IMDC cohort), progression-free survival (PFS; trial-database cohort), and OS. RESULTS The IMDC cohort included 73 black versus 3,381 (UM) and 1,236 (M) white patients. The trial-database cohort included 21 black versus 1,040 (UM) and 431 (M) white patients. Median OS for black versus white patients was 18.5 versus 25.8 months in the IMDC group and 21.0 versus 25.6 months in the trial-database group. Differences in OS were not significant in multivariable analysis in the IMDC group (hazard ratio [HR] M , 1.0; 95% CI, 0.7 to 1.5; HR UM , 1.1; 95% CI, 0.8 to 1.4) and trial-database (HR M , 1.5; 95% CI, 0.8 to 2.7; HR UM , 1.4; 95% CI, 0.8 to 2.6) cohorts. TTF for black patients was shorter in the UM IMDC cohort (HR UM , 1.4; 95% CI, 1.1 to 1.8; P = .003), but not in the M analysis. PFS was shorter for black patients in both analyses in the trial-database cohort (HR M , 2.3; 95% CI, 1.4 to 3.9; P = .002; HR UM , 2.3; 95% CI, 1.4 to 3.9; P = .002). CONCLUSION Black patients had more IMDC risk factors and worse outcomes with TKIs versus white patients. Race was not an independent predictor of OS. Strategies to understand biologic determinants of outcomes for minority patients are needed to optimize care.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.037
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.253
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueJCO Global OncologySame topicRenal cell carcinoma treatmentFrench-language works237,207